XML 41 R14.htm IDEA: XBRL DOCUMENT

IMPAIRMENT OF ROYALTIES BUYOUT	3 Months Ended
IMPAIRMENT OF ROYALTIES BUYOUT	Mar. 31, 2015
IMPAIRMENT OF ROYALTIES BUYOUT [Abstract]
IMPAIRMENT OF ROYALTIES BUYOUT	NOTE 8– IMPAIRMENT OF ROYALTIES BUYOUT During the period ended March 31, 2015 the Company recorded expenses related to the impairment of our royalties buyout asset amounting to $316,000 due to anticipated lower sales of MGuard Prime in the future resulting from industry preferences for drug eluting stents. The expense is recorded under “Restructuring and impairment expenses” in the consolidated statements of operations.